Trademark: 86835146
Status Date
Tuesday, October 8, 2019
Registration Number
5876999
Registration Date
Tuesday, October 8, 2019
Filing Date
Tuesday, December 1, 2015
Published for Opposition
Tuesday, July 23, 2019
5 Pharmaceutical preparations for the treatment of cancers and pharmaceutical preparations for the treatment of other proliferative diseases, namely, pharmaceuticals for the treatment of endometriosis, pharmaceuticals for the treatment of Polycystic Ovary Syndrome and pharmaceuticals for the treatment of tubal disease; monoclonal antibodies for the treatment of cancers and monoclonal antibodies for the treatment of other proliferative diseases, namely, endometriosis, Polycystic Ovary Syndrome and tubal disease, gene expression profiles or other molecular indicators or markers, namely, nucleic acid sequences and chemical reagents for medical purposes
10 Drug delivery devices, namely, drug delivery systems; injection devices for pharmaceutical preparations for the treatment of cancers and other proliferative diseases, namely, endometriosis, Polycystic Ovary Syndrome and tubal disease; diagnostic devices, namely, biosensor analyzers for detecting cancers and other proliferative diseases, namely, endometriosis, Polycystic Ovary Syndrome and tubal disease, medical imaging apparatus for diagnosing cancers and other proliferative diseases, namely, endometriosis, Polycystic Ovary Syndrome and tubal disease, immunoanalyzers, namely, immunochemical testing equipment for medical use; medical testing equipment in the nature of medical instruments for analyzing and identifying bacteria in the nature of bacteriologic analyzers, for manual or for automated analysis for use in measuring or testing of biological samples in medical and clinical applications for the treatment of cancers and other proliferative diseases, namely, endometriosis, Polycystic Ovary Syndrome and tubal disease
42 Chemical, biological and pharmaceutical research and development in the field of cancers and other proliferative diseases; conducting clinical trials for others in the field of cancers and other proliferative diseases
Mar 23, 2022
Teas Change Of Correspondence Received
Mar 23, 2022
Teas Change Of Domestic Representatives Address
Mar 23, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 23, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 8, 2019
Registered-Principal Register
Jul 23, 2019
Official Gazette Publication Confirmation E-Mailed
Jul 23, 2019
Published For Opposition
Jul 3, 2019
Notification Of Notice Of Publication E-Mailed
Jun 19, 2019
Approved For Pub - Principal Register
Jun 19, 2019
Previous Allowance Count Withdrawn
Jun 18, 2019
Case Returned To Examination
Jun 14, 2019
Notice Of Allowance Cancelled
Jun 14, 2019
Petition To Director - Change Basis - Granted
Jun 14, 2019
Assigned To Petition Staff
May 17, 2019
Teas Petition To Amend Basis Received
Dec 19, 2018
Notice Of Approval Of Extension Request E-Mailed
Dec 17, 2018
Extension 2 Granted
Dec 17, 2018
Extension 2 Filed
Dec 17, 2018
Teas Extension Received
Jun 15, 2018
Notice Of Approval Of Extension Request E-Mailed
Jun 13, 2018
Extension 1 Granted
Jun 13, 2018
Extension 1 Filed
Jun 13, 2018
Teas Extension Received
Jan 2, 2018
Noa E-Mailed - Sou Required From Applicant
Nov 7, 2017
Official Gazette Publication Confirmation E-Mailed
Nov 7, 2017
Published For Opposition
Oct 18, 2017
Notification Of Notice Of Publication E-Mailed
Sep 29, 2017
Exparte Appeal Terminated
Sep 29, 2017
Approved For Pub - Principal Register
Sep 28, 2017
Examiner's Amendment Entered
Sep 28, 2017
Assigned To Lie
Sep 28, 2017
Notification Of Examiners Amendment E-Mailed
Sep 28, 2017
Examiners Amendment E-Mailed
Sep 28, 2017
Examiners Amendment -Written
Sep 26, 2017
Notification Of Subsequent Final Emailed
Sep 26, 2017
Subsequent Final Emailed
Sep 26, 2017
Subsequent Final Refusal Written
Sep 19, 2017
Teas/Email Correspondence Entered
Sep 19, 2017
Correspondence Received In Law Office
Sep 19, 2017
Teas Response To Office Action Received
Mar 21, 2017
Notification Of Non-Final Action E-Mailed
Mar 21, 2017
Non-Final Action E-Mailed
Mar 21, 2017
Non-Final Action Written
Mar 2, 2017
Ex Parte Appeal-Instituted
Mar 2, 2017
Jurisdiction Restored To Examining Attorney
Mar 2, 2017
Exparte Appeal Received At Ttab
Feb 28, 2017
Teas/Email Correspondence Entered
Feb 28, 2017
Correspondence Received In Law Office
Feb 28, 2017
Teas/Email Correspondence Entered
Feb 28, 2017
Correspondence Received In Law Office
Feb 28, 2017
Teas Request For Reconsideration Received
Feb 28, 2017
Teas Request For Reconsideration Received
Sep 2, 2016
Notification Of Final Refusal Emailed
Sep 2, 2016
Final Refusal E-Mailed
Sep 2, 2016
Final Refusal Written
Aug 31, 2016
Teas/Email Correspondence Entered
Aug 30, 2016
Correspondence Received In Law Office
Aug 30, 2016
Teas Response To Office Action Received
Mar 21, 2016
Notification Of Non-Final Action E-Mailed
Mar 21, 2016
Non-Final Action E-Mailed
Mar 21, 2016
Non-Final Action Written
Mar 20, 2016
Assigned To Examiner
Dec 5, 2015
Notice Of Pseudo Mark E-Mailed
Dec 4, 2015
New Application Office Supplied Data Entered In Tram
Dec 4, 2015
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
